Stock Screener App

Gratuito -

Installare

Drug Manufacturers - General

61.13

0.92% 0.47

Bristol Myers Squibb Co (BMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BMY Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Bristol Myers Squibb Co Borsa (BMY) Ultime notizie

Bristol Myers Squibb’s Reblozyl meets trial goals for alpha-thalassemia - Investing.com

Bristol-Myers Squibb (BMY) Gets Price Target Raise by Piper Sand - GuruFocus

BMY: Promising Phase 2 Results for Reblozyl in Alpha-Thalassemia Study - GuruFocus

Large-Cap Stock Analysis 2026: Vertiv, HCA Healthcare, Bristol-Myers SquibbNews and Statistics - IndexBox

China Universal Asset Management Co. Ltd. Purchases New Stake in Bristol Myers Squibb Company $BMY - Defense World

Down 25%, Should You Buy the Dip on Bristol Myers Squibb? - The Motley Fool

Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026? - The Globe and Mail

Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus - Finviz

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday - Benzinga

Barclays initiates Bristol-Myers Squibb stock coverage at overweight - Investing.com

ICICI Prudential Asset Management Co Ltd Grows Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Stem Cell and Regenerative Therapy Markets, 2022-2025 & - GlobeNewswire

Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance

Barclays initiates Bristol-Myers Squibb stock coverage at overweight By Investing.com - Investing.com UK

Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions - Reuters

What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)? - Finviz

Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma - GlobeNewswire Inc.

Bristol Myers Squibb (NYSE:BMY) Delivers Stability While S&P 500 Stays Volatile - Kalkine Media

FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma - Finviz

Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development - Yahoo Finance

Bristol-Myers Squibb Co (NYSE:BMY) Offers a High Yield and Durable Dividend for Income Investors - ChartMill

We Like Bristol-Myers Squibb's (NYSE:BMY) Earnings For More Than Just Statutory Profit - simplywall.st

FDA accepts BMS protein degrader for review; Disc rare disease drug rejected - Yahoo Finance

Bristol Myers Squibb Company $BMY Shares Sold by Public Sector Pension Investment Board - MarketBeat

Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight – Company AnnouncementFT.com - Financial Times

Iberdomide FDA Milestone Puts Fresh Focus On Bristol Myers Squibb Hematology - Yahoo Finance

U.S. FDA accepts Bristol Myers Squibb's NDA for iberdomide in multiple myeloma - marketscreener.com

Can BMY's Growth Portfolio Counter Legacy Drugs Decline in 2026? - TradingView

Bristol Myers Squibb gains FDA nod for multiple myeloma drug - Traders Union

FDA accepts Bristol Myers Squibb’s new drug application for iberdomide - Investing.com

Vanguard Group Inc. Has $8.84 Billion Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

FDA accepts Bristol Myers Squibb’s new drug application for iberdomide By Investing.com - Investing.com Canada

Bristol-Myers Squibb's Marketing Application for Cancer Therapy Accepted for Review by FDA - marketscreener.com

U.S. Food and Drug Administration accepts Bristol Myers Squibb's new drug application for iberdomide - marketscreener.com

Skandinaviska Enskilda Banken AB publ Has $167.77 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat

Colrain Capital LLC Has $8.03 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead? - Finviz

Bristol Myers Squibb Company $BMY Shares Acquired by M&G PLC - MarketBeat

Bristol Myers Squibb Company $BMY Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat

PNC Financial Services Group Inc. Sells 480,848 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Shell Asset Management Co. Has $1.52 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat

Assetmark Inc. Buys 34,057 Shares of Bristol Myers Squibb Company $BMY - Defense World

Bristol-Myers Squibb (BMY) Stock Analysis: Is Its 4.15% Dividend Yield Enough for Investors? - DirectorsTalk Interviews

Short Interest in Bristol Myers Squibb Company (NYSE:BMY) Drops By 19.1% - MarketBeat

Berkshire Asset Management LLC PA Trims Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat

Bristol Myers Squibb Company $BMY Shares Acquired by Aberdeen Group plc - MarketBeat

Bristol-Myers Squibb Co (BMY) Stock Price, Trades & News - GuruFocus

Bristol Myers (BMY) Receives FDA Orphan Drug Status for Follicul - GuruFocus

Bristol-Myers Squibb Earnings Strength And Pipeline Shape Future Valuation - simplywall.st

Here's What Analysts Are Saying About Bristol-Myers Squibb Company (BMY) - Finviz

Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY) - Insider Monkey

Bristol Myers Squibb signs to Life Science Cares National Campaign to advance health equity and fight food insecurity - ROI-NJ

Caprock Group LLC Invests $2.99 Million in Bristol Myers Squibb Company $BMY - MarketBeat

Bristol Myers Squibb Company $BMY Stock Holdings Lessened by Cibc World Market Inc. - MarketBeat

What Does the Market Think About Bristol-Myers Squibb Co? - Benzinga

LSV Asset Management Purchases 138,119 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Bristol Myers Squibb Company $BMY Shares Sold by Rhumbline Advisers - MarketBeat

Krilogy Financial LLC Grows Position in Bristol Myers Squibb Company $BMY - MarketBeat

Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Brokerages - MarketBeat

Illinois Municipal Retirement Fund Increases Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Caisse Des Depots ET Consignations Sells 21,113 Shares of Bristol Myers Squibb Company $BMY - MarketBeat

Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth - Insider Monkey

PFE

$26.76

0.44%

NVO

$40.24

15.33%

GILD

$151.46

0.52%

AMGN

$377.37

0.90%

MRK

$122.98

0.62%

NVS

$164.92

1.35%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters